- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Essex pursues advanced MR imaging
Essex of Columbia, MD, has announced a one-year extension of its partnership with the University of Maryland School of Medicine to continue developing the ImSyn optoelectronic image processor for advanced MRI techniques.By using laser optics with
Essex of Columbia, MD, has announced a one-year extension of its partnership with the University of Maryland School of Medicine to continue developing the ImSyn optoelectronic image processor for advanced MRI techniques.
By using laser optics with high-speed digital electronics, the company believes ImSyn could provide video-rate imaging without the use of supercomputers. Essex believes ImSyn could accelerate research and, eventually, clinical use of functional brain mapping, tumor ablation techniques for the breast and brain, and intraoperative image-guided surgery. Essex also plans to use ImSyn in microscopy and radar image processing applications.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
